Brief: Nymox Announces Relocation Of Company Headquarters To Switzerland
07/05/2018 14:03
Nymox Pharmaceutical Corp NYMX.O :
* NYMOX ANNOUNCES RELOCATION OF COMPANY HEADQUARTERS TO
SWITZERLAND
* NYMOX PHARMACEUTICAL CORP - INITIATED PROCESS OF
RELOCATING
COMPANY HEADQUARTERS FROM NASSAU, BAHAMAS TO ZUG IN SWITZERLAND
* NYMOX PHARMACEUTICAL CORP - PREPARING FOR SCALE-UP &
COMMERCIALIZATION FOR FEXAPOTIDE TRIFLUTATE AS A COMPLETELY NEW
TREATMENT OPTION
* NYMOX PHARMACEUTICAL - COMMERCIALIZATION FOR FEXAPOTIDE
TRIFLUTATE FOR MEN SUFFERING FROM PROSTATE PROBLEMS ASSOCIATED
WITH AGING & PROSTATE ENLARGEMENT
* NYMOX PHARMACEUTICAL CORP - EXPECTS TO REPORT ON EUROPEAN
REGULATORY REVIEW PROCESS BY END OF Q3 2018
Source text for Eikon: ID:nGNXbmZZbl
Further company coverage: NYMX.O
Recent news on Nymox Pharmaceutical
See all newsBrief: Nymox Says Required To Resubmit Application To DKMA
Brief: Nymox Pharmaceutical Corp Says Terminated Employment Of Christopher R Riley As CFO (June 27)
Brief: Nymox Announces Appointment Of Christopher R. Riley As Chief Financial Officer
Brief: Nymox Appeals Deficiency Letter
U.S. STOCKS ON THE MOVE-Pot stocks, Nymox, Zynerba